• Molecular NameMequitazine
  • SynonymMequitazina [INN-Spanish]; Mequitazina [Spanish]; Mequitazinum [INN-Latin]
  • Weight322.476
  • Drugbank_IDDB01071
  • ACS_NO29216-28-2
  • Show 2D model
  • LogP (experiment)4.5
  • LogP (predicted, AB/LogP v2.0)4.78
  • pkaN/A
  • LogD (pH=7, predicted)1.98
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-2.82
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.01
  • No.of HBond Donors0
  • No.of HBond Acceptors2
  • No.of Rotatable Bonds2
  • TPSA31.78
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn antihistamine.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmMequitazine is extensively metabolized in mammalian species. Mequitazine i s primarily converted to S-oxidized and 3-hydroxylated compounds. Hydroxylation pathway plays a major role in human metabolism of mequitazine and is mediated by CYP2D6.
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A